Edition:
United States

Daiichi Sankyo Co Ltd (4568.T)

4568.T on Tokyo Stock Exchange

3,758JPY
20 Apr 2018
Change (% chg)

¥34 (+0.91%)
Prev Close
¥3,724
Open
¥3,723
Day's High
¥3,804
Day's Low
¥3,720
Volume
1,253,900
Avg. Vol
2,378,974
52-wk High
¥4,241
52-wk Low
¥2,284

Latest Key Developments (Source: Significant Developments)

Vaxart Announces $5 Mln Inavir Revenue Milestone
8:00am EDT 

April 20 (Reuters) - Vaxart Inc ::VAXART ANNOUNCES $5 MILLION INAVIR® REVENUE MILESTONE.VAXART - NOTIFIED BY DAIICHI SANKYO CO THAT SALES OF INAVIR EXCEEDED ¥20 BILLION IN FISCAL YEAR 2017, TRIGGERING A $5 MILLION MILESTONE PAYMENT TO CO.VAXART INC - PAYMENT IS EXPECTED IN Q2 OF 2018.  Full Article

IM lowers conversion price of 2nd series convertible bonds to 3,070 won/share
Wednesday, 28 Mar 2018 07:04am EDT 

March 28 (Reuters) - IM Co Ltd <101390.KQ> ::* Says it lowered conversion price of 2nd series convertible bonds to 3,070 won/share from 3,215 won/share, effective March 28.  Full Article

Daiichi Sankyo completes share repurchase
Thursday, 22 Mar 2018 09:58pm EDT 

March 23 (Reuters) - Daiichi Sankyo Co Ltd <4568.T>:Says it accumulatively repurchased 15.7 million shares for 50 billion yen in total as of March 22.Share repurchase plan was disclosed on Oct. 31, 2017.  Full Article

Fortis Healthcare Gets Court Order Relating To Daiichi Sankyo Co Case
Thursday, 22 Mar 2018 09:13am EDT 

March 22 (Reuters) - Fortis Healthcare Ltd ::GETS COURT ORDER RELATING TO DAIICHI SANKYO COMPANY LIMITED CASE.COURT RESTRAINED RESPONDENTS/JUDGEMENT DEBTORS FROM TRANSFERRING SHARES/NCRP/ OPTIONALLY CONVERTIBLE DEBENTURES IN CO.CO ALSO PROHIBITED AND RESTRAINED FROM PERMITTING ANY SUCH TRANSFER OR MAKING SUCH PAYMENT.SAYS ‍COURT RESTRAINED RESPONDENTS/ JUDGEMENT DEBTORS FROM RECEIVING PAYMENT OF DIVIDENDS​.  Full Article

Daiichi Sankyo Aligns U.S. Commercial Operations To Current Portfolio, Upcoming Cancer Pipeline
Wednesday, 28 Feb 2018 02:00pm EST 

Feb 28 (Reuters) - Daiichi Sankyo ::DAIICHI SANKYO, INC. ALIGNS U.S. COMMERCIAL OPERATIONS TO CURRENT PORTFOLIO AND UPCOMING CANCER PIPELINE.DAIICHI SANKYO - ‍AS PART OF REORGANIZATION, CO WILL REDUCE HEADCOUNT BY ABOUT 280 EMPLOYEES FROM VARIOUS LOCATIONS IN THE U.S.​.  Full Article

Medrx signs joint development contract with DAIICHI SANKYO
Wednesday, 28 Feb 2018 01:39am EST 

Feb 28(Reuters) - Medrx Co Ltd <4586.T>:Says it signed a joint development contract with DAIICHI SANKYO COMPANY, LIMITED <<<4568.T>>>, regarding development candidates using Nano-sized Colloid Transdermal System owned by the company .  Full Article

IM issues 2nd tranche convertible bonds worth 7.5 bln won
Thursday, 28 Dec 2017 02:43am EST 

Dec 28 (Reuters) - IM Co Ltd <101390.KQ> ::Says it completed issuance of 2nd tranche unregistered and unsecured private convertible bonds worth 7.5 billion won .  Full Article

R&I affirms Daiichi Sankyo's rating at "AA" and says negative outlook-R&I
Friday, 1 Dec 2017 02:45am EST 

Dec 1 (Reuters) - Daiichi Sankyo Co Ltd <4568.T>:Rating and Investment Information, Inc. (R&I) affirmed the company's rating at "AA"-R&I.Rating outlook negative-R&I.  Full Article

Daiichi Sankyo to merge with unit Asubio Pharma
Thursday, 30 Nov 2017 01:30am EST 

Nov 30 (Reuters) - Daiichi Sankyo Co Ltd <4568.T>:Says it will merge with wholly owned unit Asubio Pharma Co., Ltd., effective April 1, 2018 .Says unit will be dissolved after merger .  Full Article

IM to buy IM DIGITAL PHIL for 5.43 bln won
Monday, 27 Nov 2017 04:53am EST 

Nov 27 (Reuters) - IM Co Ltd <101390.KQ> ::Says it plans to buy IM DIGITAL PHIL, Inc, a Philippine Auto Focus Module firm, for 5.43 billion won .  Full Article

BRIEF-‍Daiichi Sankyo And Darwinhealth Enter Exclusive Research Collaboration For Novel Cancer Target Initiative​

* ‍DAIICHI SANKYO AND DARWINHEALTH ENTER EXCLUSIVE RESEARCH COLLABORATION FOR NOVEL CANCER TARGET INITIATIVE​